New trials to address the anemia of lower-risk MDS [MDS Professional Report]
![New trials to address the anemia of lower-risk MDS [MDS Professional Report]](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/17b9b160380c660bc06c1e1fa1454e89.jpg)
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Mar 27, 2024 ·
27m 58s
Drs Nikolaos Papadantonakis of Emory, Atlanta, US, and Moshe Mittelman, Tel-Aviv, Israel, discuss trials presented in American Society of Hematology (ASH) 2023 meeting. They provide some data on luspatercept, imetelstat,...
show more
Drs Nikolaos Papadantonakis of Emory, Atlanta, US, and Moshe Mittelman, Tel-Aviv, Israel, discuss trials presented in American Society of Hematology (ASH) 2023 meeting. They provide some data on luspatercept, imetelstat, roxodustat and Ker-050.
show less
Information
| Author | PI Media |
| Website | - |
| Tags |
-
|
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
